Brian Dorsey, VP Product Development at Somaxon Pharmaceuticals, Inc. (SOMX), sold 5,000 shares at $18.02 ($78K) on 2007-04-27, disclosed to the SEC on 2007-04-27.
Scheduled sale ($78k) by VP Product Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.04 | 4,000 | $60K | 77.0% |
| 2 | $18.02 | 339 | $6K | 7.8% |
| 3 | $18.02 | 661 | $12K | 15.2% |
| Total | $15.64 avg | 5,000 | $78K | 100% |
| Filing → |
| SPRY | SELL | 2024-08-21 | $750K | — | Filing → |
| SPRY | SELL | 2024-08-15 | $390K | — | Filing → |
| APRI | BUY | 2014-12-30 | $11K | — | Filing → |